The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras
- PMID: 8806689
The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras
Abstract
p53 is known to suppress oncogenic cell transformation, inhibit cell growth, induce apoptosis and activate and repress gene transcription. To investigate the relationships between these functions, we have examined various mutant forms of p53 for their abilities to perform each activity. This study has shown that growth inhibition is not a prerequisite for apoptotic cell death as these two functions are separate and alternative activities of p53. Additionally, we have demonstrated that the ability of p53 to suppress transformation (by adenovirus E1a and activated Ras) correlates with its ability to induce apoptosis and not with its ability to inhibit cell growth. Although p53 is thought to inhibit growth through the transactivation of p21WAFI, our study has demonstrated that transcriptional activation and repression are neither sufficient nor necessary for growth inhibition. This indicates that p53 has more than one mechanism for inhibiting cell growth and that another type of biochemical function must be involved. Furthermore, we have shown that transcriptional activation and repression may each be necessary, and the combination of these activities may even be sufficient, for p53-dependent apoptosis. In summary, our results have provided new information about the cellular and biochemical mechanisms through which p53 acts as a tumor suppressor.
Similar articles
-
Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.Genes Dev. 2004 Jun 1;18(11):1317-30. doi: 10.1101/gad.1165204. Genes Dev. 2004. PMID: 15175263 Free PMC article.
-
A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.Oncogene. 2001 Feb 8;20(6):659-68. doi: 10.1038/sj.onc.1204139. Oncogene. 2001. PMID: 11313999
-
Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.Oncogene. 1996 Aug 1;13(3):589-98. Oncogene. 1996. PMID: 8760300
-
The p53 tumor suppressor gene and gene product.Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review.
-
Decision making by p53: life, death and cancer.Cell Death Differ. 2003 Apr;10(4):431-42. doi: 10.1038/sj.cdd.4401183. Cell Death Differ. 2003. PMID: 12719720 Review.
Cited by
-
Activation of heat shock transcription factor 1 in atherosclerosis.Am J Pathol. 2003 May;162(5):1669-76. doi: 10.1016/S0002-9440(10)64301-5. Am J Pathol. 2003. PMID: 12707051 Free PMC article.
-
Apoptosis by p53: mechanisms, regulation, and clinical implications.Springer Semin Immunopathol. 1998;19(3):345-62. doi: 10.1007/BF00787230. Springer Semin Immunopathol. 1998. PMID: 9540161 Review. No abstract available.
-
Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell.J Clin Invest. 1998 Apr 1;101(7):1326-42. doi: 10.1172/JCI316. J Clin Invest. 1998. PMID: 9525975 Free PMC article.
-
Association of mesenchymal cells and immunoglobulins with differentiating epithelial cells.BMC Dev Biol. 2001;1:11. doi: 10.1186/1471-213x-1-11. Epub 2001 Jun 22. BMC Dev Biol. 2001. PMID: 11439174 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous